ACTRON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actron, and what generic alternatives are available?
Actron is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in ACTRON is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Actron
A generic version of ACTRON was approved as ketoprofen by TEVA on December 22nd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACTRON?
- What are the global sales for ACTRON?
- What is Average Wholesale Price for ACTRON?
Summary for ACTRON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 166 |
| DailyMed Link: | ACTRON at DailyMed |
US Patents and Regulatory Information for ACTRON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer | ACTRON | ketoprofen | TABLET;ORAL | 020499-001 | Oct 6, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
